Stocks/DNLI

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

DNLI

↓ PDF (Pro)
Denali Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$18.55
-0.64%today
MKT CAP
$3.2B
-7.1% · 1Y
Earnings History
-10.8%
+2.1%
+2.4%
+2.5%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$18.55
Low
$25.00
Analyst Mean
$35.64
High
$42.00
14 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-4.3x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-45.7%
Debt / Equity4.17x
Free Cash Flow$-244,188,752
Insider Ownership9.1%
Institutional Ownership100.0%
Short % of Float10.17%
Days to Cover8.0d
1 Week-6.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
WATTS RYAN JChief Executive OfficerSale35,198$16.50$0.58M2026-01-06
SCHUTH ALEXANDER OChief Financial OfficerSale17,218$16.50$0.28M2026-01-06
WATTS RYAN JChief Executive OfficerStock78,960$0.00$0.00M2026-01-02
SCHUTH ALEXANDER OChief Operating OfficerStock57,700$0.00$0.00M2026-01-02
VAN HAUWERMEIREN TIMOTHYDirectorStock10,632$0.00$0.00M2025-11-04
Top Holders
HolderType% HeldValueΔ SharesAs of
Vanguard Group Incinstitution8.23%$0.26B+8.88%2025-12-31
Blackrock Inc.institution8.01%$0.25B+3.46%2025-12-31
BAILLIE GIFFORD & COinstitution7.76%$0.24B+6.21%2025-12-31
T. Rowe Price Investment Management, Inc.institution4.57%$0.14B+28.65%2025-12-31
Temasek Holdings (Private) Ltdinstitution4.42%$0.14B+30.94%2025-12-31
State Street Corporationinstitution3.95%$0.12B+14.62%2025-12-31
FMR, LLCinstitution3.84%$0.12B-3.83%2025-12-31
NORGES BANKinstitution3.23%$0.10B+29.70%2025-12-31
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCinstitution3.14%$0.10B-8.81%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.64%$0.08B+11.50%2025-12-31
Price (T.Rowe) Associates Incinstitution2.47%$0.08B-14.28%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund2.17%$0.07B+6.98%2026-03-31
VANGUARD WORLD FUND-Vanguard U.S. Growth Fundfund1.91%$0.06B+7.79%2026-02-28
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fundfund1.89%$0.06B+8.39%2025-12-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund1.87%$0.06B-7.69%2026-03-31
SmallCap World Fund Incfund1.46%$0.05B-28.05%2025-12-31
T. Rowe Price Small-Cap Stock Fund, Inc.fund1.37%$0.04B+18.55%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fundfund1.07%$0.03B+8.74%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.01%$0.03B+7.08%2025-12-31
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fundfund0.92%$0.03B+0.00%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for DNLI.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.